Oncolytic viruses are being studied in clinical trials as a new way of treating cancer. This type of treatment uses viruses to kill cancer cells, though the viruses will not make you sick or affect healthy cells. Instead, oncolytic viruses are injected into a tumor and cause tumor cells to burst, which activates the immune system. Oncolytic viruses are being studied in combination with immune checkpoint inhibitors to further activate the immune system and kill cancer cells.
Visit the links below to learn how oncolytic viruses work and how they are being studied in people with cancer, including MBC.
How Oncolytic Viruses Work
- National Cancer Institute: Using Oncolytic Viruses to Treat Cancer
- Cancer Research Institute: Introduction to Oncolytic Virus Therapy
- MedCity News: Using Viruses to Kill Tumors and Fight Breast Cancer
Patient-Friendly Information on MBC Clinical Trials Studying Oncolytic Viruses
- City of Hope: Oncolytic Virus Clinical Trial for People with Metastatic Triple-Negative Breast Cancer
- CURE: Oncolytic Virus Clinical Trial for People With Advanced Breast Cancer
- Mayo Clinic: Measles Virus-Based Immunovirotherapy for MBC
- Metastatic Trial Search: Trials That Include Oncolytic Viruses
- Solid Tumor Trials: Trials That May Include Oncolytic Viruses
Last Modified on September 30, 2022